These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 25008926)

  • 21. Host-specific adaptation of HIV-1 subtype B in the Japanese population.
    Chikata T; Carlson JM; Tamura Y; Borghan MA; Naruto T; Hashimoto M; Murakoshi H; Le AQ; Mallal S; John M; Gatanaga H; Oka S; Brumme ZL; Takiguchi M
    J Virol; 2014 May; 88(9):4764-75. PubMed ID: 24522911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa.
    Brumme Z; Wang B; Nair K; Brumme C; de Pierres C; Reddy S; Julg B; Moodley E; Thobakgale C; Lu Z; van der Stok M; Bishop K; Mncube Z; Chonco F; Yuki Y; Frahm N; Brander C; Carrington M; Freedberg K; Kiepiela P; Goulder P; Walker B; Ndung'u T; Losina E
    Clin Infect Dis; 2009 Sep; 49(6):956-64. PubMed ID: 19663693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome.
    Ammaranond P; van Bockel DJ; Petoumenos K; McMurchie M; Finlayson R; Middleton MG; Davenport MP; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD
    J Immunol; 2011 Jan; 186(1):479-88. PubMed ID: 21115730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in impact of HLA class I allele expression on HIV-1 plasma virus loads at a population level over time.
    Koga M; Kawana-Tachikawa A; Heckerman D; Odawara T; Nakamura H; Koibuchi T; Fujii T; Miura T; Iwamoto A
    Microbiol Immunol; 2010 Apr; 54(4):196-205. PubMed ID: 20377748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage.
    Chopera DR; Woodman Z; Mlisana K; Mlotshwa M; Martin DP; Seoighe C; Treurnicht F; de Rosa DA; Hide W; Karim SA; Gray CM; Williamson C;
    PLoS Pathog; 2008 Mar; 4(3):e1000033. PubMed ID: 18369479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1.
    Miura T; Brockman MA; Brumme ZL; Brumme CJ; Pereyra F; Trocha A; Block BL; Schneidewind A; Allen TM; Heckerman D; Walker BD
    J Virol; 2009 Jan; 83(1):140-9. PubMed ID: 18971283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paediatric non-progression following grandmother-to-child HIV transmission.
    Tsai MH; Muenchhoff M; Adland E; Carlqvist A; Roider J; Cole DK; Sewell AK; Carlson J; Ndung'u T; Goulder PJ
    Retrovirology; 2016 Sep; 13(1):65. PubMed ID: 27608713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C.
    Wright JK; Novitsky V; Brockman MA; Brumme ZL; Brumme CJ; Carlson JM; Heckerman D; Wang B; Losina E; Leshwedi M; van der Stok M; Maphumulo L; Mkhwanazi N; Chonco F; Goulder PJ; Essex M; Walker BD; Ndung'u T
    J Virol; 2011 Apr; 85(8):3996-4006. PubMed ID: 21289112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.
    Kiepiela P; Leslie AJ; Honeyborne I; Ramduth D; Thobakgale C; Chetty S; Rathnavalu P; Moore C; Pfafferott KJ; Hilton L; Zimbwa P; Moore S; Allen T; Brander C; Addo MM; Altfeld M; James I; Mallal S; Bunce M; Barber LD; Szinger J; Day C; Klenerman P; Mullins J; Korber B; Coovadia HM; Walker BD; Goulder PJ
    Nature; 2004 Dec; 432(7018):769-75. PubMed ID: 15592417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations.
    Bailey JR; Williams TM; Siliciano RF; Blankson JN
    J Exp Med; 2006 May; 203(5):1357-69. PubMed ID: 16682496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early evolution of human leucocyte antigen-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C-infected women.
    Chopera DR; Ntale R; Ndabambi N; Garrett N; Gray CM; Matten D; Abdool Karim Q; Abdool Karim S; Williamson C
    AIDS; 2017 Jan; 31(2):191-197. PubMed ID: 27755110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective Effect of HLA-B*5701 and HLA-C -35 Genetic Variants in HIV-Positive Caucasians from Northern Poland.
    Leszczyszyn-Pynka M; Aksak-Wąs B; Urbańska A; Parczewski M
    PLoS One; 2015; 10(6):e0127867. PubMed ID: 26068923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations.
    Schommers P; Martrus G; Matschl U; Sirignano M; Lütgehetmann M; Richert L; Hope TJ; Fätkenheuer G; Altfeld M
    J Virol; 2016 Aug; 90(16):7579-7586. PubMed ID: 27279617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential immune escape mutations under inferred selection pressure in HIV-1 strains circulating in Medellín, Colombia.
    Arcia D; Ochoa R; Hernández JC; Álvarez CM; Díaz FJ; Velilla PA; Acevedo-Sáenz L
    Infect Genet Evol; 2019 Apr; 69():267-278. PubMed ID: 30808498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa.
    Farinre O; Gounder K; Reddy T; Tongo M; Hare J; Chaplin B; Gilmour J; Kanki P; Mann JK; Ndung'u T
    Retrovirology; 2021 May; 18(1):11. PubMed ID: 33952315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection.
    Thobakgale CF; Prendergast A; Crawford H; Mkhwanazi N; Ramduth D; Reddy S; Molina C; Mncube Z; Leslie A; Prado J; Chonco F; Mphatshwe W; Tudor-Williams G; Jeena P; Blanckenberg N; Dong K; Kiepiela P; Coovadia H; Ndung'u T; Walker BD; Goulder PJ
    J Virol; 2009 Oct; 83(19):10234-44. PubMed ID: 19605475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients.
    Crawford H; Lumm W; Leslie A; Schaefer M; Boeras D; Prado JG; Tang J; Farmer P; Ndung'u T; Lakhi S; Gilmour J; Goepfert P; Walker BD; Kaslow R; Mulenga J; Allen S; Goulder PJ; Hunter E
    J Exp Med; 2009 Apr; 206(4):909-21. PubMed ID: 19307327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice.
    Salgado M; Swanson MD; Pohlmeyer CW; Buckheit RW; Wu J; Archin NM; Williams TM; Margolis DM; Siliciano RF; Garcia JV; Blankson JN
    J Virol; 2014 Mar; 88(6):3340-52. PubMed ID: 24390323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virological and immunological factors associated with HIV-1 differential disease progression in HLA-B 58:01-positive individuals.
    Chopera DR; Mlotshwa M; Woodman Z; Mlisana K; de Assis Rosa D; Martin DP; Abdool Karim S; Gray CM; Williamson C;
    J Virol; 2011 Jul; 85(14):7070-80. PubMed ID: 21613398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.